Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VYNE | Common Stock | Award | $0 | +75K | +45.95% | $0.00 | 238K | Mar 17, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VYNE | Stock Options | Award | $0 | +75K | $0.00 | 75K | Mar 17, 2022 | Common Stock | 75K | $0.61 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of VYNE Therapeutics Inc. |
F2 | The awards vest over four years, 25% on March 31, 2023 and 6.25% every three months thereafter, ending on March 31, 2026. |